[
    {
        "question": "For sputum smear to come positive on ZN staining there should be minimum:-",
        "exp": "Sputum smear microscopy for tubercle bacilli is positive when there are at least 10,000 organisms present per ml of sputum. ZN staining in RNTCP: Acid fast bacilli of TB; 'Rod shaped' with 'beaded appearance'. >10,000 bacilli per ml sputum must be present for a positive result.",
        "cop": 4,
        "opa": "100 bacilli per per ml sputum",
        "opb": "1000 bacilli per ml sputum",
        "opc": "2000 bacilli per ml sputum",
        "opd": "10,000 bacilli per ml sputum",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "81824ec1-d6c6-43f6-89d0-e0f5d2b8c400",
        "choice_type": "single"
    },
    {
        "question": "The method of choice of tuberculosis detection in mass screening is:",
        "exp": "The method of choice of tuberculosis detection in mass screening is Sputum smear examination by direct microscopy . The reliability, cheapness and ease of direct microscopic examination has made it number one case-finding method. 2 sputum smears samples over a period of 2days is collected in pts with history of cough > 2 weeks. ZN staining. - if result is 0+/2 = SS -VE - 1+/2, 2+/2 = SS +ve",
        "cop": 3,
        "opa": "Tuberculin test",
        "opb": "Mass miniature radiography (MMR)",
        "opc": "Sputum smear examination by direct microscopy",
        "opd": "Sputum culture",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "85032565-9caf-46df-ac48-391c399757f2",
        "choice_type": "single"
    },
    {
        "question": "Multidrug resistance in TB is defined as resistance to:-",
        "exp": "Multi-drug-resistant tuberculosis(MDR-TB) is caused by bacteria resistant to treatment with at least two most powerful first-line anti-TB medications (drugs), i.e isoniazid and rifampicin. Multi-drug-resistant tuberculosis(MDR-TB) can be treated by",
        "cop": 3,
        "opa": "Streptomycin, Rifampicin and Isoniazid",
        "opb": "Streptomycin and Rifampicin",
        "opc": "Isoniazid and Rifampicin",
        "opd": "Streptomycin and Isoniazid",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "1d0df11d-0d90-4d8d-9df0-5dab564edf5c",
        "choice_type": "single"
    },
    {
        "question": "A patient came to a private practitioner and was diagnosed Tuberculosis. Within how many days he has to inform or register to district health officer?",
        "exp": "All stakeholders, both public and private, are required to notify TB cases when patients have been diagnosed or when anti-TB treatment has already been initiated. Repo the cases to the nodal public health authority \"at least on monthly basis\". \"All cases diagnosed/treated since April 7, 2012 may be notified,\" - states TB notification module of NIKSHAY.",
        "cop": 3,
        "opa": "1 day",
        "opb": "7 day",
        "opc": "30 days",
        "opd": "1 year",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "4e08a337-4fbe-4c40-bc80-cc4c679dcb0b",
        "choice_type": "single"
    },
    {
        "question": "Most peripheral Laboratory under RNTCP is:-",
        "exp": "- Most peripheral Laboratory under RNTCP is Designated microscopy center (DMC's) Designated microscopy center (DMC's) - Plains - 1/100,000 popu. - Hilly / Tribals - 1/50,000 popu. It is maintained by trained lab technician 1 TB unit - 1/5,00,000 pop. Maintained by senior TB lab supervision",
        "cop": 4,
        "opa": "Tuberculosis unit",
        "opb": "Peripheral reference laboratory",
        "opc": "Intermediate reference laboratory",
        "opd": "Designated microscopy centre",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "9fdf2b95-9f88-4109-a3e5-13d38667eaa7",
        "choice_type": "single"
    },
    {
        "question": "Every TB sputum positive patient can infect up to:-",
        "exp": "TB transmission: - Slow rise, then plateau phase, then slow fall is characteristic in India - propagative epidemic person - to person transmission. - Thus, Every TB sputum positive patient can infect up to 10-15 persons per year.",
        "cop": 3,
        "opa": "1-2 persons per year",
        "opb": "5-6 persons per year",
        "opc": "10-15 persons per year",
        "opd": "100-200 persons per year",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "bc89b3be-657c-4687-81a8-0a810b0f082b",
        "choice_type": "single"
    },
    {
        "question": "World Tuberculosis Day is celebrated on ?",
        "exp": "Impoant dates Impoant days 24th March World Tuberculosis day 7th April World health day 22nd April World eah day 1st December World AIDS day 5th June World environment day 1st July Doctors day - Theme of World TB day 2018 :\"Wanted, Leaders for TB-free world\"",
        "cop": 1,
        "opa": "24th March",
        "opb": "7th April",
        "opc": "22nd April",
        "opd": "1st December",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "d57c7c0e-34fb-4f00-91e6-10295ee795b1",
        "choice_type": "single"
    },
    {
        "question": "The DTPB approach is included under which program?",
        "exp": "National Strategic Plan (2017-2025) for TB Elimination The aim of the National Strategic Plan is to achieve elimination of TB by 2025. During plan period, targets for TB are:1. 80% reduction in TB incidence (i.e . reduction from 211 per lakh to 43 per lakh)2. 90% reduction in TB moality (i.e. reduction from 32 per lakh to 3 per lakh3 . 0% patient having catastrophic expenditure due to TB The requirements for moving towards TB elimination have been integrated into the four strategic pillars of \"Detect - Treat - Prevent - Build\" (DTPB)",
        "cop": 3,
        "opa": "National AIDS control programme",
        "opb": "National Programme for Control of Blindness",
        "opc": "National Strategic Plan for TB",
        "opd": "National malaria elimination programme",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "445daab7-0df4-41da-aa23-4fafffee5656",
        "choice_type": "single"
    },
    {
        "question": "All of the following drugs are used in the management of MDR-TB under RNTCP except",
        "exp": "PAS is an add-on agent(D GROUP) and is not a core pa of MDR-TB drug regimen. The remaining 3 drugs are being given in both intensive as well as continuation phase of the regimen.",
        "cop": 2,
        "opa": "Levofloxacin",
        "opb": "PAS",
        "opc": "Ethionamide",
        "opd": "Cycloserine",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "5dc88edd-6319-4132-ad3e-1c6a485c9b5b",
        "choice_type": "multi"
    },
    {
        "question": "A 45 years old male patient comes to OPD with cough and diarrhea since last 3 weeks. On diagnosis he is found to be HIV positive with Tuberculosis, Next line of management should be:-",
        "exp": "Guidelines for treatment of HIV+TB patients:- A is offered to all HIV-TB and HIV-MDR TB patients irrespective of CD4 count. Sta ATT first, allow it to be tolerated , then sta A. ATT treatment is same but treatment is more difficult and adverse reactions are more common. Immune reconstitution inflammatory syndrome (IRIS) : Occasionally, patients with HIV-related TB may experience a temporary exacerbation of symptoms, signs ofradiographic manifestations of TB after beginning TB treatment. This paradoxical reaction occurs in HIV-infected patients with active TB and is thought to be a result of immune restitution due to the simultaneous administration of antiretroviral and tuberculosis medication. Symptoms and signs may include high fever, lymphadenopathy, expandingintra-thoracic lesions and worsening of chest radiographicfindings",
        "cop": 1,
        "opa": "Sta ATT followed by A",
        "opb": "Sta A followed by ATT",
        "opc": "Sta ATT",
        "opd": "Sta A then sta ATT after 6-8 weeks",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "4f909b57-9997-4dcf-a972-b7d5e8f3687a",
        "choice_type": "single"
    },
    {
        "question": "RNTCP objective for cure rate is:-",
        "exp": "RNTCP National Strategic Plan 2012-17 objectives (90/90):- To achieve 90% notification rates for all cases. To achieve 90% success rate for all new and 85% for re-treatment cases. To significantly improve successful outcomes of treatment of DR-TB cases. To achieve decreased morbidity and moality of HIV associated TB. To improve outcomes of TB care in private sector. Also remember, DOTS therapy under RNTCP include: - Category-1 - New sputum smear +ve ; New sputum smear -ve. - Category-2 - Re-treatment case. - Both categories have same treatment regimen. - Regimen - 2 + 4 = Total 6 month duration. H- Isoniazid R - Rifampicin Z - Pyrazinamide E - Ethambutol",
        "cop": 3,
        "opa": "70%",
        "opb": "80%",
        "opc": "90%",
        "opd": "100%",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "296249b2-d40d-4d3e-8080-a2a8864f1fa8",
        "choice_type": "single"
    },
    {
        "question": "In a suspected TB patient, two boxes are given for sputum sample collection. They are labeled as:-",
        "exp": "- 2 sputum samples over a period of 2 days is collected in pts, with history of cough > 2weeks. - Spot sample is collected on Day-1; Morning sample is collected on Day-2. Labeling of sputum samples in RNTCP: Diagnosis as well as follow-up samples are labeled with a single LSN with a suffix 'a' for the spot sample and 'b' for morning sample.",
        "cop": 1,
        "opa": "a, b",
        "opb": "A, B",
        "opc": "1, 2",
        "opd": "Y, Z",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "4a0cce2b-3180-44d6-a471-a576c8edd290",
        "choice_type": "single"
    },
    {
        "question": "Best indicator of trend of Tuberculosis unaffected by current control measures is:-",
        "exp": "Annual risk of infection: Is the propoion of population which will be primarily infected with tuberculosis in course of 1 year. Is incidence of infection of TB. Is known as 'Tuberculosis conversion Index'. Best indicator of trend of TB unaffected by current control measures. ARI: 1-2%. For every 1% rise of ARI, there are 50 SS +ve cases /Lac population.",
        "cop": 1,
        "opa": "Annual risk of infection",
        "opb": "Prevalence of TB infection",
        "opc": "% of primary drug resistance",
        "opd": "% of multidrug resistance",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "2c5be430-8681-47f9-931d-3e70bc0adb09",
        "choice_type": "single"
    },
    {
        "question": "Anti-tubercular drug contraindicated during Pregnancy is:-",
        "exp": "- Streptomycin- It is ototoxic to the fetus and should not be used during pregnancy. - With the exception of streptomycin, the first line anti-TB drugs are safe for use in pregnancy. - Pyridoxine (vitamin B6) should be added to the drug treatmentoftuberculosisin allpregnantwomen taking isoniazid. - Pregnancy with TB: Sta ATT immediately irrespective of time of pregnancy / delivery - 2 months + 7 months - total 9 months. MDR-TB : Do MTP & then sta ATT; If MTP can't be done, sta ATT without kanamycin & ethionamide substituted with PAS till delivery.",
        "cop": 3,
        "opa": "Isoniazid",
        "opb": "Rifampicin",
        "opc": "Streptomycin",
        "opd": "Ethambutol",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "82b6d4d1-614f-4dfd-9506-5da8e8b99c14",
        "choice_type": "single"
    },
    {
        "question": "All of the following are true regarding Bedaquiline use except",
        "exp": "BEDAQUILINEPatient should be using non- hormonal based bih control measure throughout the treatment period The basic criteria for patient selection for bedaquiline is : Age of the patient should be >=18 years having MDR- TB Pregnancy is a contraindication for BDQ therapy and the patient should be using non-hormonal based bih control measure throughout the treatment period or have been postmenopausal for past 2 years; and Cardiac arrhythmia is a contraindication for BDQ treatment -XDR-TB patient is eligible for therapy",
        "cop": 3,
        "opa": "The patient >= 18 years with MDR TB is included",
        "opb": "Patient with XDR-TB is eligible for its therapy",
        "opc": "Patient should be using hormonal based bih control measure throughout the treatment period",
        "opd": "Pregnant patients are excluded",
        "subject_name": "Social & Preventive Medicine",
        "topic_name": "RNTCP",
        "id": "06be2bf1-164f-4286-a8b9-6937940293b4",
        "choice_type": "multi"
    }
]